Higher mortality in HIV-2/HTLV-1 co-infected patients with pulmonary tuberculosis in Guinea-Bissau, West Africa, compared to HIV-2-positive HTLV-1-negative patients

International Journal of Infectious Diseases

Volumn 14, Issue SUPPL. 3, 2010, Pages

  Norrgren, Hans ^a   Bamba, Sana ^b   Da Silva, Zacarias J ^c   Koivula, Tuija ^d   Andersson, Sören ^d  

^a LUND UNIVERSITY   (Sweden)

^b Hospital Raoul Follereau   (Guinea-Bissau)

^c National Public Health Laboratory   (Guinea-Bissau)

^d SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

CD4; HIV 1; HIV 2; HTLV 1; Mortality; Tuberculosis

Indexed keywords

CD4 ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOSUPPRESSIVE TREATMENT; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; CD4 LYMPHOCYTE COUNT; CD4-CD8 RATIO; FEMALE; GUINEA-BISSAU; HIV INFECTIONS; HIV-1; HIV-2; HTLV-I INFECTIONS; HUMANS; MALE; TUBERCULOSIS, PULMONARY;

EID: 77957375964     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2009.11.040     Document Type: Article

References (30)

1. Corbett E.L., Watt C.J., Walker N., Maher D., Williams B.G., Raviglione M.C., et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003, 163:1009-1021.
2. Edlich R.F., Arnette J.A., Williams F.M. Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I). J Emerg Med 2000, 18:109-119.
3. Verdonck K., González E., Van Dooren S., Vandamme A.M., Vanham G., Gotuzzo E. Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis 2007, 7:266-281.
4. Tachibana N., Okayama A., Ishizaki J., Yokota T., Shishime E., Murai K., et al. Suppression of tuberculin skin reaction in healthy HTLV-I carriers from Japan. Int J Cancer 1988, 42:829-831.
5. Welles S.L., Tachibana N., Okayama A., Shioiri S., Ishihara S., Murai K., et al. Decreased reactivity to PPD among HTLV-I carriers in relation to virus and hematologic status. Int J Cancer 1994, 56:337-340.
6. Hisada M., Stuver S.O., Okayama A., Mueller N.E. Gender difference in skin reactivity to purified protein derivative among carriers of HTLV-I in Japan. J Acquir Immune Defic Syndr 1999, 22:302-307.
7. Schechter M., Harrison L.H., Halsey N.A., Trade G., Santino M., Moulton L.H., et al. Coinfection with human T-cell lymphotropic virus type I and HIV in Brazil. Impact on markers of HIV disease progression. JAMA 1994, 271:353-357.
8. Schechter M., Moulton L.H., Harrison L.H. HIV viral load and CD4+ lymphocyte counts in subjects coinfected with HTLV-I and HIV-1. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 15:308-311.
9. Harrison L.H., Schechter M. Coinfection with HTLV-I and HIV: increase in HTLV-I-related outcomes but not accelerated HIV disease progression?. AIDS Patient Care STDs 1998, 12:619-623.
10. Beilke M.A., Theall K.P., O'Brien M., Clayton J.L., Benjamin S.M., Winsor E.L., et al. Clinical outcomes and disease progression among patients coinfected with HIV and human T lymphotropic virus types 1 and 2. Clin Infect Dis 2004, 39:256-263.
11. Brites C., Sampaio J., Oliveira A. HIV/human T-cell lymphotropic virus coinfection revisited: impact on AIDS progression. AIDS Rev 2009, 11:8-16.
12. Bessinger R., Beilke M., Kissinger P., Jarrott C., Tabak O.F. Retroviral coinfections at a New Orleans HIV outpatient clinic. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 14:67-71.
13. Brites C., Alencar R., Gusmão R., Pedroso C., Netto E.M., Pedral-Sampaio D., et al. Co-infection with HTLV-1 is associated with a shorter survival time for HIV-1-infected patients in Bahia, Brazil. AIDS 2001, 15:2053-2055.
14. Suarez P.G. Association between HTLV-1 infection and pulmonary tuberculosis: another challenge for national tuberculosis programs?. Int J Tuberc Lung Dis 2007, 11:1048.
15. Norrgren H.R., Bamba S., Larsen O., da Silva Z., Aaby P., Koivula T., et al. Increased prevalence of HTLV-1 in patients with pulmonary tuberculosis coinfected with HIV, but not in HIV-negative patients with tuberculosis. J Acquir Immune Defic Syndr 2008, 48:607-610.
16. Pedral-Sampaio D.B., Netto E.M., Pedroso C., Brites C., Duarte M., Harrington W. Co-infection of tuberculosis and HIV/HTLV retroviruses: frequency and prognosis among patients admitted in a Brazilian hospital. Brazil J Infect Dis 1997, 1:31-36.
17. Månsson F., Alves A., Silva Z.J., Dias F., Andersson S., Biberfeld G., et al. Trends of HIV-1 and HIV-2 prevalence among pregnant women in Guinea-Bissau, West Africa: possible effect of the civil war 1998-1999. Sex Transm Infect 2007, 83:463-467.
18. Larsen O., Andersson S., da Silva Z., Hedegaard K., Sandström A., Nauclér A., et al. Prevalences of HTLV-1 infection and associated risk determinants in an urban population in Guinea-Bissau, West Africa. J Acquir Immune Defic Syndr 2000, 25:157-163.
19. Gustafson P., Gomes V.F., Vieira C.S., Rabna P., Seng R., Johansson P., et al. Tuberculosis in Bissau: incidence and risk factors in an urban community in sub-Saharan Africa. Int J Epidemiol 2004, 33:163-172.
20. Norrgren H, Bamba S, Da Silva Z, Koivula T, Andersson S., High mortality in HIV and HTLV-1 coinfected patients with pulmonary tuberculosis in Guinea-Bissau, West Africa, despite higher CD4 counts compared to HIV-positive HTLV-1 negative patients. 14th International Conference on Human Retrovirology, Salvador, Bahia, Brazil, July 1-4, 2009; OP-03.
21. Andersson S., da Silva Z., Norrgren H., Dias F., Biberfeld G. Field evaluation of alternative testing strategies for diagnosis and differentiation of HIV-1 and HIV-2 infections in an HIV-1 and HIV-2-prevalent area. AIDS 1997, 11:1815-1822.
22. Nauclér A., Winqvist N., Dias F., Koivula T., Lacerda L., Svenson B., et al. Pulmonary tuberculosis in Guinea-Bissau: clinical and bacteriological findings, human immunodeficiency virus status and short term survival of hospitalized patients. Tuber Lung Dis 1996, 77:226-232.
23. Norrgren H., Andersson S., Biague A.J., da Silva Z.J., Dias F., Nauclér A., et al. Trends and interaction of HIV-1 and HIV-2 in Guinea-Bissau, West Africa: no protection of HIV-2 against HIV-1 infection. AIDS 1999, 13:701-707.
24. Norrgren H., Da Silva Z.J., Andersson S., Biague A.J., Dias F., Biberfeld G., et al. Clinical features, immunological changes and mortality in a cohort of HIV-2-infected individuals in Bissau, Guinea-Bissau. Scand J Infect Dis 1998, 30:323-329.
25. Jaffar S, Grant AD, Whitworth J, Smith PG, Whittle H. The natural history of HIV-1 and HIV-2 infections in adults in Africa: a literature review. Bull World Health Organ 2004; 82:462-469. Erratum: Bull World Health Organ 2004; 82:571.
26. Holmgren B., Da Silva Z., Vastrup P., Larsen O., Andersson S., Ravn H., et al. Mortality associated with HIV-1, HIV-2 and HTLV-1 single and dual infections in a middle-aged and older population in Guinea-Bissau. Retrovirology 2007, 4:85.
27. Ariyoshi K., Berry N., Cham F., Jaffar S., Schim van der Loeff M., Jobe O., et al. Quantification of human T-lymphotropic virus type I (HTLV-I) provirus load in a rural West African population: no enhancement of human immunodeficiency virus type 2 pathogenesis, but HTLV-I provirus load relates to mortality. J Infect Dis 2003, 188:1648-1651.
28. Goon P.K., Bangham C.R. Interference with immune function by HTLV-1. Clin Exp Immunol 2004, 137:234-236.
29. Casoli C., Pilotti E., Bertazzoni U. Molecular and cellular interactions of HIV/HTLV coinfection and impact on AIDS progression. AIDS Rev 2007, 9:140-149.
30. Harrison L.H., Quinn T.C., Schechter M., Human T cell lymphotropic virus type I does not increase human immunodeficiency virus viral load in vivo. J Infect Dis 1997, 175:438-440.